Product Information
IVABRADINE HCL 5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.7713 per EA under NDC 50742036260. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
5 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742036260
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214051On Market Since
7/15/2024
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 5 MG TABLET has been published 88 times since Oct 23, 2024, and over the history we have for it it has declined 83.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7713 per EA |
|---|---|
| All-time high | $4.5638 (Nov 13, 2024) |
| All-time low | $0.7713 (Jun 17, 2026) |
| 52-week high | $3.1866 |
| 52-week low | $0.7713 |
| Median price | $3.0340 |
| Average price | $2.7854 |
| Largest weekly change | -40.9% (Feb 18, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the IVABRADINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.7713 per EA (NDC 50742036260), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 83.1%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?
Since Oct 23, 2024, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7713 (Jun 17, 2026) to a high of $4.5638 (Nov 13, 2024), with a median of $3.0340 per EA.
Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IVABRADINE HCL 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures IVABRADINE HCL 5 MG TABLET?
IVABRADINE HCL 5 MG TABLET (NDC 50742036260) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification